Skip Navigation
Skip to contents

KMJ : Kosin Medical Journal

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Kosin Med J > Volume 41(2); 2026 > Article
Review article
Telecytology in head and neck cytopathology: current applications and practical considerations
Yeongjoon Kimorcid
Kosin Medical Journal 2026;41(2):126-136.
DOI: https://doi.org/10.7180/kmj.26.177
Published online: June 23, 2026

Department of Otolaryngology-Head and Neck Surgery, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea

Corresponding Author: Yeongjoon Kim, MD Department of Otolaryngology-Head and Neck Surgery, Kosin University Gospel Hospital, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 49267, Korea Tel: +82-51-990-6470 Fax: +82-51-245-8539 E-mail: yjk88ent@gmail.com
• Received: May 18, 2026   • Revised: June 8, 2026   • Accepted: June 9, 2026

© 2026 Kosin University College of Medicine.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 1,213 Views
  • 7 Download
prev next
  • Telecytology is a clinically applicable component of telepathology that enables remote cytologic assessment through digital image transmission. In head and neck practice, its primary value lies in fine-needle aspiration (FNA) workflows for thyroid nodules, cervical lymph nodes, metastatic neck masses, and salivary gland lesions, in which rapid assessment of specimen adequacy and triage for ancillary studies can affect diagnostic yield and specimen use. This review summarizes the major telecytology platforms, including static-image transmission, dynamic real-time systems, robotic microscopy, and whole-slide imaging, and discusses their use in common head and neck cytopathology settings. The evidence base is strongest for thyroid FNA, which is supported by telecytology-specific studies and the broader literature on rapid on-site evaluation (ROSE). For cervical lymph nodes, metastatic neck masses, and salivary gland lesions, telecytology primarily serves as a procedural support tool for adequacy assessment, repeat-pass decision-making, and specimen triage, rather than as a universal substitute for conventional cytopathology review. Its limitations include operator dependence, field-selection bias, image quality, the need to assess cytology specimens across multiple focal planes, workflow integration, validation, and quality assurance. Implementation is also influenced by reimbursement, medicolegal responsibility, data security, and institutional resources. Current evidence supports the selective use of telecytology, with priority given to thyroid FNA and other ROSE-linked procedures in which adequacy assessment, repeat-pass decisions, or ancillary-test triage can affect specimen management, particularly when continuous on-site cytopathology coverage is limited. Wider adoption will require standardized workflows, site-specific validation, sustainable implementation models, and careful integration of whole-slide imaging and computational tools into clinically defined use cases.
Telepathology can be defined as remote interpretation of macroscopic or microscopic pathologic images transmitted via telecommunication links for diagnosis, consultation or education [1]. Within this field, telecytology describes the remote interpretation of cytologic material using digital images [2]. Telecytology is well suited for rapid on-site evaluation (ROSE) because it can allow cytology specimens to be assessed for adequacy and preliminary triage without requiring the continuous physical presence of a cytopathologist at the procedure site [2,3]. In ROSE, the immediate objectives are to confirm specimen adequacy, determine whether additional passes are required, and guide the allocation of material for ancillary studies [3-5].
In head and neck cytopathology, those functions are clinically important because fine-needle aspiration (FNA) plays a central role in the initial evaluation of thyroid nodules, cervical lymph nodes, metastatic neck masses, and salivary gland lesions [6-8]. Immediate adequacy assessment can reduce nondiagnostic sampling and repeat procedures, while also facilitating the real-time allocation of material for cell block preparation, microbiologic studies, flow cytometry, immunocytochemistry, or molecular testing, as clinically indicated [3,6,9,10]. These functions are especially relevant in procedure-linked cytology workflows, where the clinical value of telecytology depends on timely communication between the aspirator, on-site personnel, and the remote cytopathologist. In this context, remote assessment should be evaluated by whether it can support adequacy assessment, repeat-pass decisions, and specimen allocation during FNA procedures [3,5,11,12].
Telecytology therefore combines remote cytologic assessment with procedural support for adequacy assessment and specimen triage. By allowing cytopathologists to review images transmitted from a laboratory or other remote site, telecytology can improve workflow efficiency and broaden access to cytopathology expertise in settings where continuous on-site coverage is difficult to maintain [3,5,11,12]. However, its reliability can be affected by field-selection bias, suboptimal focus, variable slide preparation quality, and the difficulty of capturing diagnostically important material distributed across multiple focal planes [2,3,13]. Those limitations are especially important in head and neck cytopathology, in which cystic, necrotic, hemorrhagic, or hypocellular aspirates can complicate adequacy assessment and downstream triage [6,8,9,14]. This review summarizes current telecytology platforms and their application to common head and neck cytopathology workflows, with an emphasis on thyroid lesions, cervical lymph nodes and metastatic neck masses, and salivary gland lesions. It also examines telecytology-assisted ROSE, specimen triage, implementation barriers, quality management, and future directions.
Several approaches have been used in telecytology, particularly static-image transmission, dynamic real-time telecytology, robotic microscopy, and whole-slide imaging (WSI) [2,3,15]. Although those approaches share the goal of enabling remote cytologic review, they differ in workflow, equipment requirements, operator dependence, cost, and suitability for ROSE [3,15]. In head and neck practice, each method is best judged by whether it can provide timely adequacy assessment, repeat-pass guidance, and specimen triage during FNA procedures [6,8,9,11,12].
Static telecytology is among the earliest and simplest approaches. Representative microscopic fields are selected at the procedure site, captured as still images, and transmitted to a remote reviewer [2,3,15]. Its main strengths are simplicity, relatively low cost, and ease of deployment, but it is highly susceptible to field-selection bias [2,3,15]. This limitation is particularly important in heterogeneous head and neck specimens, including necrotic cervical lymph node aspirates and salivary gland lesions with focal diagnostic components [6,14,16,17].
Dynamic real-time telecytology is performed using live video microscopy, with interaction between the remote cytopathologist and the on-site operator [3,6,11,12,18]. This approach is particularly well suited to ROSE because it allows immediate feedback on adequacy, the need for additional passes, and preliminary triage [3,4,6,11,12]. Recent review and validation studies define the general requirements for telecytology-assisted ROSE, whereas organ-specific feasibility data for head and neck practice come more directly from focused studies of thyroid and non-thyroid aspiration workflows [6-8,11-13].
Robotic microscopy extends dynamic telecytology by allowing the remote reviewer to directly control stage movement and focus [2,15]. This provides greater autonomy to the reviewing cytopathologist and can reduce dependence on on-site field selection, but it generally requires more sophisticated infrastructure and higher setup costs than dynamic telecytology [2,15]. Consequently, robotic microscopy might be difficult to adopt as an initial platform for routine head and neck telecytology in settings with resource constraints [15].
WSI uses digitized slides that can be reviewed remotely in a manner similar to routine digital pathology [13,19,20]. Its strengths include archiving, standardization, asynchronous consultation, and potential integration with computational tools [13,20,21].
However, cytology remains technically challenging for WSI because diagnostically relevant material can lie across multiple focal planes, often requiring approaches such as Z-stacking or extended-focus imaging [13,20]. Recent thyroid-focused evidence, including a prospective multi-reader study, suggests that WSI might be useful in selected rapid evaluation workflows, but its routine integration into real-time procedure-linked head and neck practice is still evolving [19].
The major telecytology platforms differ not only in their technical design but also in their suitability for procedure-linked head and neck cytopathology workflows (Table 1).
1. Thyroid lesions
Thyroid FNA is one of the best-established clinical applications of telecytology in head and neck practice [7,22,23]. Thyroid nodules are common, ultrasound-guided aspiration is routine, and adequacy assessment directly affects repeat aspiration, diagnostic yield, and patient care [7,9-11,24]. Thyroid cytology also benefits from a standardized category-based reporting framework through the Bethesda System for Reporting Thyroid Cytopathology, which facilitates structured evaluation of telecytology for preliminary assessment and (in selected settings) primary interpretation [7,23,25]. Recent systematic review data support the usefulness of telecytology in thyroid FNA biopsy, especially for rapid adequacy assessment and remote support where continuous on-site cytopathology is unavailable [7].
For thyroid lesions, the role of telecytology is most evident during ROSE [7,22]. An immediate review of smear adequacy can reduce nondiagnostic sampling and help determine whether additional passes are needed while the patient is still present [9-11,24]. This procedural rationale is reinforced by meta-analytic evidence showing that ROSE improves the adequacy of thyroid FNA, supporting the broad value of immediate adequacy assessment, even though specific implementation models vary among institutions [9,10,24]. The value of ROSE is particularly relevant for sparsely cellular, hemorrhagic, and cystic aspirates [9,10]. Depending on the local workflow, telecytology can also support preliminary triage for additional passes, cell block preparation, or molecular testing [3,7,22].
Although thyroid telecytology should not be assumed to be exactly equivalent to conventional microscopy in every circumstance, it currently has one of the strongest evidence bases among head and neck applications and provides the most mature model for broad implementation in head and neck cytopathology [4,7,13,22,23]. WSI can also have a role in selected thyroid rapid evaluation workflows, but current evidence should be interpreted as supportive rather than definitive for routine real-time replacement of conventional procedure-linked review [19].
2. Cervical lymph nodes and metastatic neck masses
Cervical lymph node aspiration is another important application of telecytology-assisted ROSE in head and neck practice [6,8,26]. Compared with thyroid aspirates, lymph node specimens often require a broader differential diagnosis, including reactive and infectious lymphadenopathy, granulomatous inflammation, metastatic carcinoma, cystic metastatic squamous cell carcinoma, and lymphoma [27]. In this setting, telecytology can be useful not only for confirming adequacy but also for prompting additional sampling and triage for ancillary studies when a lymphoproliferative or metastatic process is suspected [3,4,6].
Telecytology can preserve some procedural advantages of on-site cytopathology during ultrasound-guided aspiration of neck masses when direct cytopathologist presence is impractical [6,26]. Dynamic telecytopathology has been reported to be comparable to conventional microscopy for ROSE in ultrasound-guided FNA of non-thyroid head and neck lesions, supporting real-time review when on-site cytopathology is unavailable [6]. This can be particularly important for necrotic or cystic neck masses, in which viable diagnostic material can be limited and real-time feedback can prompt additional targeted sampling during a single procedure [6,14,26].
When lymphoma is suspected, telecytology can assist in recognizing the need to allocate additional material for flow cytometry, cell block preparation, or other ancillary studies [3,4,6]. However, definitive classification still depends on adequate procurement, ancillary testing, and full morphologic assessment [4,27]. For this reason, in cervical lymph node lesions, the major value of telecytology lies in real-time procedural support, adequacy assessment, and specimen triage, rather than complete diagnostic replacement of conventional workflows [6,8,26].
3. Salivary gland lesions
Salivary gland FNA poses specific challenges for telecytology because the diagnostic material is often heterogeneous, focally distributed, and dependent on subtle cytomorphologic and background features [18,28-31]. Although FNA is widely used for the preoperative evaluation of salivary gland masses, interpretation can be limited by cytomorphologic overlap, matrix-rich backgrounds, cystic changes, and the difficult distinction between benign neoplasms, low-grade malignancies, and inflammatory lesions [17,29,31]. The Milan System for Reporting Salivary Gland Cytopathology provides a standardized framework for reporting salivary gland FNA and communicating diagnostic uncertainty and risk categories, with further refinement available in its second edition [29,30].
Because direct evidence for salivary gland telecytology is more limited than that for thyroid FNA, its role should be framed primarily in terms of ROSE-related tasks, including adequacy assessment, repeat-pass guidance, and specimen triage [2,3,28-30]. In outpatient or image-guided salivary gland aspiration, telecytology can help to confirm whether representative lesional material has been obtained, guide additional sampling, and support the allocation of material for ancillary studies when on-site cytopathology support is unavailable [2,3,28-30]. Given that focal diagnostic components and subtle cytomorphologic distinctions can be missed when field selection or image quality is suboptimal, salivary gland telecytology is best used as an adjunctive tool, rather than a standalone diagnostic method [2,3,15,17,29].
The current organ-specific roles of telecytology in thyroid, cervical lymph node, and salivary gland lesions are summarized in Table 2.
ROSE is one of the most clinically relevant applications of telecytology in head and neck cytopathology [3-5,12]. The immediate goal of ROSE is not necessarily to establish a final diagnosis, but to determine whether diagnostically meaningful material has been obtained and whether additional passes are needed while the patient is still undergoing the procedure [3,4,11]. In many head and neck lesions, this function is clinically important because nondiagnostic or poorly targeted aspirates can otherwise lead to repeat procedures, diagnostic delays, and missed opportunities for ancillary testing [3,6,22,24,26]. The general workflow of telecytology-assisted ROSE in head and neck FNA, including image acquisition, remote review, adequacy feedback, and specimen triage, is summarized in Fig. 1.
In a telecytology-assisted ROSE model, slide preparation and image acquisition are performed at or near the procedure site, and then the reviewing cytopathologist evaluates the transmitted images remotely and provides adequacy feedback in real time [3,8,11,12]. Depending on the situation, static-image transmission, live video microscopy, WSI, or robotic microscopy with remote control of stage movement and focus can be used [2,3,15]. The reviewing cytopathologist can provide immediate feedback on adequacy and the need for additional passes and offer guidance on material allocation for cell block preparation, flow cytometry, microbiologic studies, or molecular testing [3,5,6,11]. Review, validation, and implementation studies support this telecytology-assisted ROSE workflow [3-5,12,13,16]. Organ-specific studies in thyroid FNA and non-thyroid head and neck FNA also provide direct evidence for feasibility in head and neck practice [6-8,11,23].
In head and neck practice, the main value of telecytology-assisted ROSE lies in workflow support and specimen triage [3,5,6,11,12]. For thyroid lesions, telecytology can support immediate adequacy assessment and help reduce unsatisfactory sampling in selected practice settings, and a broad ROSE literature supports the clinical importance of adequacy assessment during thyroid FNA [7,9,19,24]. For cervical lymph nodes and other metastatic neck masses, telecytology can help redirect sampling toward viable lesional tissue and facilitate timely triage when metastatic carcinoma, lymphoma, or infection is suspected [6,8,26]. For salivary gland lesions, the diagnostic role of telecytology can be more limited than for other organs because of cytomorphologic overlap, lesion heterogeneity, and the focal distribution of diagnostic material [17,29,30]. Nevertheless, telecytology can still help to reduce clearly inadequate sampling and improve real-time communication between the aspirator and the cytopathologist during ROSE [3,5].
Because telecytology-assisted ROSE depends on the reliability of the entire workflow, including smear preparation, image acquisition, slide navigation, communication, validation, and quality assurance, these operational issues are discussed separately in the Practical Challenges and Quality Considerations section and summarized in Table 3 [4,5,13].
The principal implementation barriers and quality-management considerations relevant to head and neck telecytology are summarized in Table 3.
Despite its clinical potential, telecytology in head and neck practice is constrained by several implementation- and quality-related issues [2-5,14]. These limitations are particularly significant because head and neck aspirates can be heterogeneous, cystic, necrotic, hemorrhagic, or hypocellular, and diagnostically important material can be focal, rather than evenly distributed across the slide [6,8,14,17]. Accordingly, the reliability of telecytology depends not only on the interpretive expertise of the remote cytopathologist but also on slide preparation, image acquisition, field selection, and clear communication within the procedural workflow [2,3,11,13].
Operator dependence remains one of the most persistent limitations of telecytology [2-4,8,12,16]. In static-image systems, diagnostic value is strongly influenced by whether the on-site operator selects representative fields [2,3,15]. In dynamic telecytology, this limitation is partly alleviated because the reviewer can request additional fields, focus adjustment, or changes in magnification; however, remote assessment still depends on the on-site operator’s ability to navigate the slide, maintain focus, and respond efficiently to reviewer requests [3,8,11,12,15]. This issue is especially relevant for heterogeneous head and neck lesions, such as salivary gland aspirates and cystic or necrotic cervical lymph node specimens, in which diagnostically relevant material can be limited or unevenly distributed [6,8,14,17].
Image quality also directly affects telecytology performance [2,3,13]. Adequate resolution, color fidelity, illumination, and focus are essential when preserving cytomorphologic detail for remote review [13]. Cytology also poses technical challenges that are less prominent in many histologic applications: diagnostically relevant single cells and cell clusters can lie at different focal depths [13]. Consequently, cytology WSI can require Z-stacking or other multifocal scanning approaches, which can increase the scanning time, file size, and review burden [13,19]. Those technical requirements help explain why WSI-based cytology remains more challenging than many histologic WSI applications, particularly when rapid adequacy assessment is required during procedures [13]. Recent thyroid FNA data suggest that WSI can be feasible for rapid adequacy assessment in selected settings, but broad cytology ROSE implementation still requires workflow-specific validation and quality control [19].
Reliable telecytology requires the coordination of specimen preparation, image acquisition, remote review, and real-time communication [3,4,11,13]. It is most effective within a standardized process that defines who prepares the smear, who captures static images or navigates the slide dynamically, how adequacy feedback is communicated, and how requests for additional passes or ancillary testing are transmitted [3,4,11]. Validation and quality assurance are therefore essential for safe implementation. Current telecytology and digital cytology recommendations emphasize institution-specific validation of hardware, software, personnel competency, and the integrated workflow for the intended clinical use before routine deployment [4,5,13].
Beyond technical performance, reimbursement, medicolegal responsibility, data governance, documentation, and long-term sustainability remain important barriers [4,5,13]. These issues vary according to institutional resources, payer systems, and national regulatory frameworks. Collectively, they could determine whether telecytology remains a limited pilot service or becomes a durable component of head and neck cytopathology practice [4,5,13].
The future development of telecytology in head and neck practice should prioritize clinically validated workflows, rather than the adoption of digital platforms alone. The recent telecytology and digital cytology literature provides a framework for remote assessment, validation, and implementation, but organ-specific expansion in head and neck practice will require evidence from thyroid and non-thyroid aspiration workflows [4-8,14,23]. In the near term, telecytology is likely to have the greatest effect on adequacy assessment, specimen triage, and access to cytopathology expertise while maintaining diagnostic quality, reproducibility, and quality assurance [4,5,13].
WSI is initially best suited for applications that do not depend on real-time slide navigation, including archiving, asynchronous consultation, education, standardized remote review, and quality assurance [13]. Its use for procedure-linked ROSE remains challenging because cytology specimens often require assessment across multiple focal planes and can therefore require Z-stacking or extended-focus approaches [13,19]. Recent thyroid FNA data suggest that WSI can support rapid evaluation in selected workflows, but the evidence supports careful workflow-specific implementation, rather than universal replacement of conventional microscopy or dynamic telecytology [19]. A hybrid model might be appropriate, with dynamic telecytology used for real-time ROSE and WSI used for consultation, education, archiving, and quality assurance [5,13,19].
At present, direct evidence for artificial intelligence (AI)-assisted telecytology in head and neck cytopathology remains limited. Most available discussions address digital cytology and AI at a general implementation level, rather than validated organ-specific telecytology workflows [13,20,21]. Among head and neck applications, thyroid FNA is the most plausible initial setting because adequacy assessment, identification of diagnostically informative fields, and recognition of suboptimal digital preparations are central to ROSE; however, this should be regarded as a research priority rather than established clinical practice [5,13,19,21]. Evidence is particularly sparse for cervical lymph node, metastatic neck mass, and salivary gland telecytology. Future studies should therefore evaluate AI as an assistive tool for field selection, image-quality control, and adequacy support, with external validation, workflow integration, prospective monitoring, and clear governance before clinical deployment [4,5,20,21].
Early adoption should focus on settings with clear unmet needs, including distributed aspiration services, institutions with insufficient cytopathology coverage, and high-volume FNA workflows in which rapid adequacy assessment directly influences specimen management [5,8,11]. Initial programs should define roles for specimen preparation, image acquisition, remote review, adequacy feedback, and ancillary-test triage. Diagnostic concordance, adequacy outcomes, turnaround times, technical failures, and communication delays should be monitored before pilot programs are expanded to broad institutional or regional networks [4,5,12,13].
In the Korean healthcare setting, the near-term feasibility of telecytology in head and neck practice depends on several contextual factors. Direct nationwide data on the institutional distribution of head and neck FNA cytology services in Korea are not currently available. However, two nationwide cytopathology surveys provide indirect insight into the Korean cytopathology landscape. In a national cytopathology survey conducted by the Korean Society for Cytopathology, gynecologic cytology specimens, which accounted for the largest portion of the cell pathology workload, were processed predominantly by commercial laboratories (83.4%), even though those laboratories represented only about 21% of the 214 participating institutions in 2020 [32]. Comparable institution-stratified data for non-gynecologic cytology, including FNA, were not provided in that survey. A separate nationwide multicenter survey by the Korean Society of Endocrine Pathologists, which focused specifically on thyroid FNA reporting practices across 74 institutes, revealed substantial heterogeneity across participating centers in the use of standardized reporting frameworks and reported malignancy rates [33]. Those findings suggest heterogeneity in Korean cytopathology practice, although they do not directly establish the institutional distribution of head and neck FNA cytology services [32,33]. In that context, telecytology might be particularly relevant as a mechanism for extending cytopathology expertise across geographically separated procedure sites and supporting ROSE [3,6]. Distributed networks linking tertiary cytopathology services or high-volume cytology laboratories with affiliated satellite clinics performing ultrasound-guided head and neck FNA could therefore be considered a plausible early implementation model in this setting.
Despite that potential, several structural barriers constrain system-wide adoption. Korean digital pathology recommendations have noted that broad implementation will depend partly on the establishment of appropriate reimbursement within the national health insurance system [34]. In the more specific context of telecytology or telecytology-based ROSE, a dedicated reimbursement pathway does not appear to be clearly established, which could limit the sustainability of formal programs beyond institutionally supported pilot models. Cross-institutional transmission of cytologic images and associated clinical information must comply with Korea's data protection regulations, including the Personal Information Protection Act [35]. Implementation therefore requires institution-level governance, secure image transmission, access control, audit trails, validation protocols, and quality assurance procedures [34,36].
A staged implementation strategy might be more suitable than immediate system-wide deployment. Initial deployment could focus on dynamic video-based telecytology within single institutions or tightly governed hospital networks, where technical validation, operator training, documentation standards, and quality assurance can be centrally managed [3,34]. Subsequent expansion to broad regional networks would depend on the development of reimbursement mechanisms, interoperability standards, and validation frameworks and the clarification of medicolegal responsibilities [34,36]. Recent Korean experience with digital pathology recommendations and quality assurance programs, including national digital cytopathology quality assurance, indicates that the technical and professional infrastructure for digital cytology is gradually developing [34,36,37]. However, routine clinical implementation of telecytology in head and neck practice will require further evidence, policy support, and workflow-specific validation.
Telecytology has a clinically relevant role in head and neck cytopathology, particularly when it is integrated into FNA-based ROSE. Its clearest value lies in adequacy assessment, repeat-pass decision-making, and specimen triage for thyroid lesions, cervical lymph nodes and metastatic neck masses, and salivary gland lesions [3-8,12,26]. Thyroid FNA currently has the strongest evidence base among head and neck telecytology applications [7,9,22]. In non-thyroid head and neck applications, telecytology mainly supports viable tissue targeting, ancillary-test triage, and communication between the aspirator and the cytopathologist, rather than serving as a complete diagnostic replacement [6,8,17,26,30].
Telecytology should therefore not be regarded as a simple digital substitute for conventional microscopy. Its reliability depends on representative field selection, image quality, slide navigation, operator training, workflow design, validation, and quality assurance [2-4,14]. Those requirements are particularly important in head and neck cytopathology, where cystic, necrotic, hemorrhagic, hypocellular, or heterogeneous aspirates can limit the reliability of remote review and adequacy assessment [6,14,17].
Broad implementation will require workflow-specific validation, not just the adoption of digital platforms. Institutions considering telecytology should begin with high-yield ROSE-linked use cases, monitor diagnostic concordance and adequacy outcomes, and expand their programs gradually as technical reliability, personnel competency, reimbursement pathways, data governance, and local cytopathology resources mature [4,5,12,13,34-37].

Conflicts of interest

No potential conflict of interest relevant to this article was reported.

Funding

None.

Author contributions

All the work was done by Yeongjoon Kim.

Fig. 1.
Suggested workflow for telecytology-assisted rapid on-site evaluation in head and neck fine-needle aspiration (FNA). At the procedure site, the procedural team or trained on-site personnel performs FNA, slide preparation, rapid staining, image acquisition, and image transmission. At the remote site, the cytopathologist reviews the transmitted images, determines specimen adequacy, provides a preliminary cytomorphologic impression, and recommends additional passes or allocation of material for ancillary testing when needed. Specimen triage is then performed by the procedure-site team in communication with the remote cytopathologist. WSI, whole-slide imaging.
kmj-26-177f1.jpg
Table 1.
Technical modalities of telecytology and their practical implications in head and neck cytopathology
Modality Description Strengths Limitations and suitability for H&N FNA
Static-image transmission Selected microscopic fields are captured as still images at the procedure site and transmitted to a remote reviewer Simple implementation, low equipment cost, and ease of deployment across sites with limited infrastructure Highly vulnerable to field-selection bias because the remote reviewer evaluates only the fields selected on site; this is particularly limiting in heterogeneous H&N specimens, such as necrotic cervical lymph nodes and focal salivary gland lesions
Dynamic real-time telecytology (live video) Live video microscopy with two-way interaction between the on-site operator and the remote cytopathologist; the reviewer can request additional fields, focus adjustment, and changes in magnification Provides real-time adequacy feedback, supports immediate decisions about additional passes and ancillary triage, and is well suited to telecytology-assisted ROSE Diagnostic value still depends on operator skill in slide navigation and stable image transmission; performance can decline with limited bandwidth or inexperienced operators. Nevertheless, this modality is a practical initial platform for many H&N FNA workflows, particularly when rapid adequacy feedback is required
Robotic microscopy A motorized microscope stage allows the remote reviewer to directly control field selection and focus without assistance from on-site cytology personnel manipulating the slide Provides greater reviewer autonomy than operator-driven live video systems and reduces dependence on on-site field-selection skill Higher equipment and integration costs; requires dedicated infrastructure and IT support; less practical as an entry-level platform for resource-constrained H&N services
Whole-slide imaging The entire glass slide is digitized at high resolution; the remote reviewer evaluates the digital slide using dedicated viewer software, often with multifocal image acquisition, such as Z-stacking Supports asynchronous review, archiving, standardization, second-opinion consultation, and integration with computational and AI tools Cytology specimens span multiple focal planes, often requiring Z-stacking or extended-focus imaging, which increases scan time, file size, and review burden; routine integration into procedure-linked H&N ROSE workflows is still evolving

H&N, head and neck; FNA, fine-needle aspiration; ROSE, rapid on-site evaluation; IT, information technology; AI, artificial intelligence.

Table 2.
Organ-specific applications of telecytology in head and neck lesions
Lesion category Evidence strength for telecytology Reporting framework Primary value of telecytology Key considerations and limitations
Thyroid lesions Strongest among H&N applications The Bethesda System for Reporting Thyroid Cytopathology, third edition Supports adequacy assessment during ultrasound-guided FNA; has been reported to reduce unsatisfactory rates in selected thyroid FNA workflows; guides preliminary triage for additional passes, cell block preparation, and molecular testing; and provides the most mature model among H&N applications Sparsely cellular, hemorrhagic, and cystic aspirates remain susceptible to misclassification; WSI evidence is supportive but not yet definitive for routine real-time replacement of conventional procedure-linked review
Cervical lymph nodes and metastatic neck masses Moderate; supported by focused dynamic telecytology studies of H&N non-thyroid lesions No single dominant cytopathology framework; the Sydney System for Reporting Lymph Node FNAC has been proposed Provides real-time procedural support during ultrasound-guided aspiration; is particularly valuable for necrotic or cystic neck masses; and can trigger ancillary triage, including flow cytometry, cell block preparation, and microbiologic studies, when lymphoma or atypical metastasis is suspected A broad differential diagnosis, including reactive, infectious, granulomatous, metastatic, and lymphomatous processes, limits the diagnostic conclusiveness of cytology alone; definitive lymphoma classification still requires adequate tissue procurement and a full ancillary workup
Salivary gland lesions Limited; not specifically validated in dedicated telecytology studies The Milan System for Reporting Salivary Gland Cytopathology, second edition Supports adequacy assessment, repeat-sampling decisions, and preservation of material for ancillary testing in distributed outpatient and image-guided settings; also facilitates communication between the proceduralist and the reviewing pathologist Cytomorphologic overlap, matrix-rich backgrounds, heterogeneous cellularity, and focal diagnostic components increase susceptibility to field-selection bias; this modality is best framed as an adjunct to, rather than a substitute for, conventional cytopathology review

H&N, head and neck; FNA, fine-needle aspiration; WSI, whole-slide imaging; FNAC, fine-needle aspiration cytology.

Table 3.
Practical challenges and implementation considerations in head and neck telecytology
Domain Key challenges Mitigation strategies and implementation considerations
Image and specimen quality Adequate resolution, color fidelity, illumination, and focus are required to preserve cytomorphologic detail; cytology specimens span multiple focal planes, which complicates static-image and WSI-based review, and Z-stacking increases scan time and file size Use validated image-acquisition equipment, calibrated displays, and standardized staining protocols. For WSI cytology, adopt Z-stacking or extended-focus imaging when feasible. Perform institution-specific validation before clinical deployment
Operator and reviewer dependence Diagnostic value depends on the on-site operator’s skill in slide navigation, focus adjustment, and field selection, as well as on the remote reviewer’s familiarity with digital cytology. This is particularly relevant for heterogeneous H&N aspirates, including cystic, necrotic, hemorrhagic, and hypocellular specimens Provide structured training and competency assessment for both on-site and remote personnel. Consider trained clinical imaging assistants for ROSE coverage when cytology personnel are unavailable. Conduct periodic concordance audits
Validation and quality assurance Telecytology platforms must be validated against conventional microscopy for the intended clinical use; performance may vary by platform, personnel, specimen type, and workflow Apply society-level validation recommendations. Document hardware, software, personnel competency, and workflow. Monitor concordance, adequacy, turnaround time, and technical failure rates
Workflow integration and communication Telecytology performance depends on coordinated specimen preparation, image acquisition, remote review, and bidirectional communication during procedures; ad hoc implementation increases the risk of nondiagnostic outcomes Define standard operating procedures specifying who prepares the smear, who navigates the slide, how adequacy feedback is communicated, and how requests for additional passes and ancillary testing are transmitted. Integrate telecytology with the LIS and procedure-room workflow
Regulatory and data governance Cross-institutional transmission of cytologic images and clinical information must comply with applicable data protection regulations; medicolegal responsibilities for remote diagnoses are not uniformly defined across jurisdictions Implement secure image transmission, access controls, audit trails, and institution-level governance. In Korea, ensure compliance with the Personal Information Protection Act. Use institutional and inter-institutional agreements to clarify reviewer responsibilities and reporting authority
Reimbursement and economic sustainability Dedicated reimbursement pathways for telecytology and telecytology-based ROSE remain limited or absent in many systems, including the Korean National Health Insurance framework; capital costs and ongoing maintenance can constrain adoption beyond pilot programs Begin with low-overhead dynamic video platforms within single institutions or governed networks. Evaluate reimbursement feasibility and institutional cost-sharing models. Share infrastructure across affiliated centers. Build on existing Korean digital pathology and digital cytopathology QA experience

WSI, whole-slide imaging; H&N, head and neck; ROSE, rapid on-site evaluation; LIS, laboratory information system; QA, quality assurance.

  • 1. Farahani N, Pantanowitz L. Overview of telepathology. Surg Pathol Clin 2015;8:223–31.ArticlePubMed
  • 2. Thrall M, Pantanowitz L, Khalbuss W. Telecytology: clinical applications, current challenges, and future benefits. J Pathol Inform 2011;2:51.ArticlePubMedPMC
  • 3. Lin O. Telecytology for rapid on-site evaluation: current status. J Am Soc Cytopathol 2018;7:1–6.ArticlePubMedPMC
  • 4. Lin O, Alperstein S, Barkan GA, Cuda JM, Kezlarian B, Jhala D, et al. American Society of Cytopathology Telecytology validation recommendations for rapid on-site evaluation (ROSE). J Am Soc Cytopathol 2024;13:111–21.ArticlePubMed
  • 5. Krishnamurthy S. Current landscape and emerging opportunities for using telecytology for rapid on-site assessment in cytopathology. Cancer Cytopathol 2025;133:e70027.ArticlePubMedPMC
  • 6. Khurana KK, Xu W, Wang D, Swarnkar A. Rapid on-site evaluation with dynamic telecytopathology for ultrasound-guided fine-needle aspiration of head and neck nonthyroid lesions. J Pathol Inform 2015;6:19.ArticlePubMedPMC
  • 7. Oteri V, Piane S, Cocci E. The use of telecytology for the evaluation of thyroid nodules fine-needle aspiration biopsy specimens: a systematic review. J Endocrinol Invest 2024;47:2397–406.ArticlePubMedPMCPDF
  • 8. Martyn S, Wheeldon L. Telecytology: remote rapid on-site evaluation for ultrasound-guided head and neck fine needle aspiration utilising a clinical imaging assistant with an extended practice role. Cytopathology 2024;35:371–7.ArticlePubMed
  • 9. Issa PP, McCarthy C, Hussein M, Albuck AL, Emad E, Shama M, et al. Assessing adequacy: a meta-analysis of rapid onsite evaluation of thyroid nodules. J Surg Res 2024;296:523–31.ArticlePubMed
  • 10. Michael CW, Kameyama K, Kitagawa W, Azar N. Rapid on-site evaluation (ROSE) for fine needle aspiration of thyroid: benefits, challenges and innovative solutions. Gland Surg 2020;9:1708–15.ArticlePubMedPMC
  • 11. Lin O, Rudomina D, Feratovic R, Sirintrapun SJ. Rapid on-site evaluation using telecytology: a major cancer center experience. Diagn Cytopathol 2019;47:15–9.ArticlePubMedPMCPDF
  • 12. Boothe P, Martinez-Amador C, Hajarat T, Gonsalves C, Donthi D, Mukhtar F, et al. Validation and implementation of telecytology at an academic medical center using digital cameras and Microsoft Teams software. J Am Soc Cytopathol 2024;13:329–39.ArticlePubMed
  • 13. Kim D, Sundling KE, Virk R, Thrall MJ, Alperstein S, Bui MM, et al. Digital cytology part 1: digital cytology implementation for practice: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol 2024;13:86–96.ArticlePubMed
  • 14. Seo YJ, Shin H, Lee HW, Jung HR. Causes of necrotic features in fine-needle aspirates from cervical lymph nodes. J Pathol Transl Med 2021;55:60–7.ArticlePubMedPMCPDF
  • 15. Yao K, Li Z. Review of different platforms to perform rapid onsite evaluation via telecytology. Cytopathology 2020;31:379–84.ArticlePubMedPDF
  • 16. Colella G, Cannavale R, Flamminio F, Foschini MP. Fine-needle aspiration cytology of salivary gland lesions: a systematic review. J Oral Maxillofac Surg 2010;68:2146–53.ArticlePubMed
  • 17. Saoud C, Bailey GE, Graham A, Bonilla LM, Sanchez SI, Maleki Z. Pitfalls in salivary gland cytology. Acta Cytol 2024;68:194–205.ArticlePubMedPDF
  • 18. Kern I, Gabric S, Triller N, Pozek I. Telecytology for rapid assessment of cytological specimens. J Telemed Telecare 2012;18:86–9.ArticlePubMedPDF
  • 19. Ahmed MS, Klippel-Almaraz D, Amin SE, Sura GH, Kundu UR, Yu W, et al. Utility of whole-slide imaging for rapid evaluation of thyroid FNA: a multireader prospective study. Cancer Cytopathol 2025;133:e70046.ArticlePubMedPMC
  • 20. Kim D, Thrall MJ, Michelow P, Schmitt FC, Vielh PR, Siddiqui MT, et al. The current state of digital cytology and artificial intelligence (AI): global survey results from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol 2024;13:319–28.ArticlePubMed
  • 21. Kim D, Sundling KE, Virk R, Thrall MJ, Alperstein S, Bui MM, et al. Digital cytology part 2: artificial intelligence in cytology: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force. J Am Soc Cytopathol 2024;13:97–110.ArticlePubMed
  • 22. Lin DM, Tracht J, Rosenblum F, Kouba E, Bahl D, Patel A, et al. Rapid on-site evaluation with telecytology significantly reduced unsatisfactory rates of thyroid fine-needle aspiration. Am J Clin Pathol 2020;153:342–5.ArticlePubMedPDF
  • 23. Canberk S, Behzatoglu K, Caliskan CK, Gelmez S, Kayhan KC, Aydemir SF, et al. The role of telecytology in the primary diagnosis of thyroid fine-needle aspiration specimens. Acta Cytol 2020;64:323–31.ArticlePubMedPDF
  • 24. de Koster EJ, Kist JW, Vriens MR, Borel Rinkes IH, Valk GD, de Keizer B. Thyroid ultrasound-guided fine-needle aspiration: the positive influence of on-site adequacy assessment and number of needle passes on diagnostic cytology rate. Acta Cytol 2016;60:39–45.ArticlePubMedPDF
  • 25. Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2023;33:1039–44.ArticlePubMed
  • 26. Ganguly A, Giles TE, Smith PA, White FE, Nixon PP. The benefits of on-site cytology with ultrasound-guided fine needle aspiration in a one-stop neck lump clinic. Ann R Coll Surg Engl 2010;92:660–4.ArticlePubMedPMC
  • 27. Al-Abbadi MA, Barroca H, Bode-Lesniewska B, Calaminici M, Caraway NP, Chhieng DF, et al. A proposal for the performance, classification, and reporting of lymph node fine-needle aspiration cytopathology: the Sydney System. Acta Cytol 2020;64:306–22.ArticlePubMedPDF
  • 28. Policardo F, Mule' A, Rossi ED. Salivary gland fine-needle aspiration: the current and future landscape. Surg Pathol Clin 2024;17:347–58.ArticlePubMed
  • 29. Pusztaszeri M, Rossi ED, Faquin WC. Update on salivary gland fine-needle aspiration and the Milan System for Reporting Salivary Gland Cytopathology. Arch Pathol Lab Med 2024;148:1092–104.ArticlePubMedPDF
  • 30. Rossi ED, Baloch Z, Barkan G, Foschini MP, Kurtycz D, Pusztaszeri M, et al. Second edition of the Milan System for Reporting Salivary Gland Cytopathology: refining the role of salivary gland FNA. J Am Soc Cytopathol 2024;13:67–77.ArticlePubMed
  • 31. Huang YT, Ho CY, Ou CY, Huang CC, Lee WT, Tsai SW, et al. Evaluation of fine needle aspiration cytopathology in salivary gland tumors under Milan System: challenges, misdiagnosis rates, and clinical recommendations. Biomedicines 2023;11:1973.ArticlePubMedPMC
  • 32. Hong SA, Jung H, Kim SS, Jin MS, Pyo JS, Jeong JY, et al. Current status of cytopathology practice in Korea: impact of the coronavirus pandemic on cytopathology practice. J Pathol Transl Med 2022;56:361–9.ArticlePubMedPMCPDF
  • 33. Kim M, Park HJ, Min HS, Kwon HJ, Jung CK, Chae SW, et al. The use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: a nationwide multicenter survey by the Korean Society of Endocrine Pathologists. J Pathol Transl Med 2017;51:410–7.ArticlePDF
  • 34. Chong Y, Kim DC, Jung CK, Kim DC, Song SY, Joo HJ, et al. Recommendations for pathologic practice using digital pathology: consensus report of the Korean Society of Pathologists. J Pathol Transl Med 2020;54:437–52.ArticlePubMedPMCPDF
  • 35. Korea Legislation Research Institute. Personal Information Protection Act [Internet]. Korea Legislation Research Institute; 2023 [cited 2026 May 3]. https://elaw.klri.re.kr/eng_service/lawView.do?hseq=62389&lang=ENG
  • 36. Chong Y, Bae JM, Kang DW, Kim G, Han HS. Development of quality assurance program for digital pathology by the Korean Society of Pathologists. J Pathol Transl Med 2022;56:370–82.ArticlePubMedPMCPDF
  • 37. Chong Y, Kwon HJ, Hong SA, Kim SS, Kim BS, Choi Y, et al. National quality assurance program using digital cytopathology: a 5-year digital transformation experience by the Korean Society for Cytopathology. J Pathol Transl Med 2025;59:320–33.ArticlePubMedPMCPDF

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • ePub LinkePub Link
      • Cite
        CITE
        export Copy
        Close
      • Download Citation
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Telecytology in head and neck cytopathology: current applications and practical considerations
        Kosin Med J. 2026;41(2):126-136.   Published online June 23, 2026
        Close
      • XML DownloadXML Download
      Figure
      • 0
      Telecytology in head and neck cytopathology: current applications and practical considerations
      Image
      Fig. 1. Suggested workflow for telecytology-assisted rapid on-site evaluation in head and neck fine-needle aspiration (FNA). At the procedure site, the procedural team or trained on-site personnel performs FNA, slide preparation, rapid staining, image acquisition, and image transmission. At the remote site, the cytopathologist reviews the transmitted images, determines specimen adequacy, provides a preliminary cytomorphologic impression, and recommends additional passes or allocation of material for ancillary testing when needed. Specimen triage is then performed by the procedure-site team in communication with the remote cytopathologist. WSI, whole-slide imaging.
      Telecytology in head and neck cytopathology: current applications and practical considerations
      Modality Description Strengths Limitations and suitability for H&N FNA
      Static-image transmission Selected microscopic fields are captured as still images at the procedure site and transmitted to a remote reviewer Simple implementation, low equipment cost, and ease of deployment across sites with limited infrastructure Highly vulnerable to field-selection bias because the remote reviewer evaluates only the fields selected on site; this is particularly limiting in heterogeneous H&N specimens, such as necrotic cervical lymph nodes and focal salivary gland lesions
      Dynamic real-time telecytology (live video) Live video microscopy with two-way interaction between the on-site operator and the remote cytopathologist; the reviewer can request additional fields, focus adjustment, and changes in magnification Provides real-time adequacy feedback, supports immediate decisions about additional passes and ancillary triage, and is well suited to telecytology-assisted ROSE Diagnostic value still depends on operator skill in slide navigation and stable image transmission; performance can decline with limited bandwidth or inexperienced operators. Nevertheless, this modality is a practical initial platform for many H&N FNA workflows, particularly when rapid adequacy feedback is required
      Robotic microscopy A motorized microscope stage allows the remote reviewer to directly control field selection and focus without assistance from on-site cytology personnel manipulating the slide Provides greater reviewer autonomy than operator-driven live video systems and reduces dependence on on-site field-selection skill Higher equipment and integration costs; requires dedicated infrastructure and IT support; less practical as an entry-level platform for resource-constrained H&N services
      Whole-slide imaging The entire glass slide is digitized at high resolution; the remote reviewer evaluates the digital slide using dedicated viewer software, often with multifocal image acquisition, such as Z-stacking Supports asynchronous review, archiving, standardization, second-opinion consultation, and integration with computational and AI tools Cytology specimens span multiple focal planes, often requiring Z-stacking or extended-focus imaging, which increases scan time, file size, and review burden; routine integration into procedure-linked H&N ROSE workflows is still evolving
      Lesion category Evidence strength for telecytology Reporting framework Primary value of telecytology Key considerations and limitations
      Thyroid lesions Strongest among H&N applications The Bethesda System for Reporting Thyroid Cytopathology, third edition Supports adequacy assessment during ultrasound-guided FNA; has been reported to reduce unsatisfactory rates in selected thyroid FNA workflows; guides preliminary triage for additional passes, cell block preparation, and molecular testing; and provides the most mature model among H&N applications Sparsely cellular, hemorrhagic, and cystic aspirates remain susceptible to misclassification; WSI evidence is supportive but not yet definitive for routine real-time replacement of conventional procedure-linked review
      Cervical lymph nodes and metastatic neck masses Moderate; supported by focused dynamic telecytology studies of H&N non-thyroid lesions No single dominant cytopathology framework; the Sydney System for Reporting Lymph Node FNAC has been proposed Provides real-time procedural support during ultrasound-guided aspiration; is particularly valuable for necrotic or cystic neck masses; and can trigger ancillary triage, including flow cytometry, cell block preparation, and microbiologic studies, when lymphoma or atypical metastasis is suspected A broad differential diagnosis, including reactive, infectious, granulomatous, metastatic, and lymphomatous processes, limits the diagnostic conclusiveness of cytology alone; definitive lymphoma classification still requires adequate tissue procurement and a full ancillary workup
      Salivary gland lesions Limited; not specifically validated in dedicated telecytology studies The Milan System for Reporting Salivary Gland Cytopathology, second edition Supports adequacy assessment, repeat-sampling decisions, and preservation of material for ancillary testing in distributed outpatient and image-guided settings; also facilitates communication between the proceduralist and the reviewing pathologist Cytomorphologic overlap, matrix-rich backgrounds, heterogeneous cellularity, and focal diagnostic components increase susceptibility to field-selection bias; this modality is best framed as an adjunct to, rather than a substitute for, conventional cytopathology review
      Domain Key challenges Mitigation strategies and implementation considerations
      Image and specimen quality Adequate resolution, color fidelity, illumination, and focus are required to preserve cytomorphologic detail; cytology specimens span multiple focal planes, which complicates static-image and WSI-based review, and Z-stacking increases scan time and file size Use validated image-acquisition equipment, calibrated displays, and standardized staining protocols. For WSI cytology, adopt Z-stacking or extended-focus imaging when feasible. Perform institution-specific validation before clinical deployment
      Operator and reviewer dependence Diagnostic value depends on the on-site operator’s skill in slide navigation, focus adjustment, and field selection, as well as on the remote reviewer’s familiarity with digital cytology. This is particularly relevant for heterogeneous H&N aspirates, including cystic, necrotic, hemorrhagic, and hypocellular specimens Provide structured training and competency assessment for both on-site and remote personnel. Consider trained clinical imaging assistants for ROSE coverage when cytology personnel are unavailable. Conduct periodic concordance audits
      Validation and quality assurance Telecytology platforms must be validated against conventional microscopy for the intended clinical use; performance may vary by platform, personnel, specimen type, and workflow Apply society-level validation recommendations. Document hardware, software, personnel competency, and workflow. Monitor concordance, adequacy, turnaround time, and technical failure rates
      Workflow integration and communication Telecytology performance depends on coordinated specimen preparation, image acquisition, remote review, and bidirectional communication during procedures; ad hoc implementation increases the risk of nondiagnostic outcomes Define standard operating procedures specifying who prepares the smear, who navigates the slide, how adequacy feedback is communicated, and how requests for additional passes and ancillary testing are transmitted. Integrate telecytology with the LIS and procedure-room workflow
      Regulatory and data governance Cross-institutional transmission of cytologic images and clinical information must comply with applicable data protection regulations; medicolegal responsibilities for remote diagnoses are not uniformly defined across jurisdictions Implement secure image transmission, access controls, audit trails, and institution-level governance. In Korea, ensure compliance with the Personal Information Protection Act. Use institutional and inter-institutional agreements to clarify reviewer responsibilities and reporting authority
      Reimbursement and economic sustainability Dedicated reimbursement pathways for telecytology and telecytology-based ROSE remain limited or absent in many systems, including the Korean National Health Insurance framework; capital costs and ongoing maintenance can constrain adoption beyond pilot programs Begin with low-overhead dynamic video platforms within single institutions or governed networks. Evaluate reimbursement feasibility and institutional cost-sharing models. Share infrastructure across affiliated centers. Build on existing Korean digital pathology and digital cytopathology QA experience
      Table 1. Technical modalities of telecytology and their practical implications in head and neck cytopathology

      H&N, head and neck; FNA, fine-needle aspiration; ROSE, rapid on-site evaluation; IT, information technology; AI, artificial intelligence.

      Table 2. Organ-specific applications of telecytology in head and neck lesions

      H&N, head and neck; FNA, fine-needle aspiration; WSI, whole-slide imaging; FNAC, fine-needle aspiration cytology.

      Table 3. Practical challenges and implementation considerations in head and neck telecytology

      WSI, whole-slide imaging; H&N, head and neck; ROSE, rapid on-site evaluation; LIS, laboratory information system; QA, quality assurance.


      KMJ : Kosin Medical Journal
      TOP